Cytochrome P4502D4 in the brain: Specific neuronal regulation by clozapine and toluene

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 342-350

  Hedlund, Eva ^a,e   Wyss, Adrian ^a   Kainu, Tommi ^d   Backlund, Maria ^a   Köhler, Christer ^b   Pelto Huikko, Markku ^c   Gustafsson, Jan Åke ^a   Warner, Margaret ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; CYTOCHROME P450; HALOPERIDOL; MIANSERIN; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG DISTRIBUTION; DRUG EFFECT; ENZYME METABOLISM; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN; CLOZAPINE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MOLECULAR SEQUENCE DATA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TOLUENE;

EID: 0029788829     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. MacPhail, R. C. Principles of identifying and characterizing neurotoxicity. Toxicol. Lett. 64-65:209-215 (1992).
2. Becking, G. C., W. K. Boyes, T. Damstra, and R. C. MacPhail. Assessing the neurotoxic potential of chemicals: a multidisciplinary approach. Environ. Res. 61:164-175 (1993).
3. Langsten, J. W., P. Ballard, J. W. Tetrud, and I. Irwin. Chronic parkinsonism in humans due to a product of meperidine-analogue synthesis. Science (Washington D. C.) 219:979-980 (1983).
4. Nelson, D. R., K. Tetsuya, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen, F. J. Gonzalez, M. J. Coon, I. C. Gunsalus, O. Gotoh, K Okuda, and D. W. Nebert. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12:1-51 (1993)
5. Wolf, C. R. Cytochrome P450s: polymorphic multigene families involved in carcinogen activation. Trends Genet. 2:209-214 (1986).
6. Guengerich, F. P. Separation and purification of multiple forms of microsomal cytochrome P-450: activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 262:3970-3979 (1977).
7. Warner, M., A. Wyss, S. Yoshida, and J.-Å. Gustafsson. Cytochrome P450 enzymes in the brain. Methods Neurosci. 22:51-66 (1994).
8. Tyndale, R. F., R. Sunahara, T. Inaba, W. Kalow, F. J. Gonzalez, and H. B. Niznik. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol. Pharmacol. 40:63-68 (1991).
9. Wyss, A., M. Warner, and J.-Å. Gustafsson. Cytochrome P450s of the 2D subfamily in the rat brain. Mol. Pharmacol 47:1148-1155 (1995).
10. Komori, M. A novel P450 expressed at high level in rat brain. Biochem. Biophys. Res. Commun. 162:721-728 (1993).
11. Gonzalez, F. J., and U. A. Meyer. Molecular genetics of the debrisoquine-sparteine polymorphism. Clin. Pharmacol. Ther. 50:233-238 (1991).
12. Armstrong, M., A. K. Daly, S. Cholerton, D. N. Bateman, and J. R. Idle. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339:1017-1018 (1992).
13. Comella, C., C. M. Tanner, C. G. Goetz, S. Gans, D. D. Rapp, and J. Fischer. Debrisoquine metabolism in Parkinson's disease. Neurology 37: 261-262 (1987).
14. Tsuneoka, Y., Y. Matsuo, K. Iwahashi, H. Takeuchi, and Y. Ichikawa. A novel cytochrome P450 2D6 mutant gene associated with Parkinson's disease. J. Biochem. 114:263-266 (1993).
15. Warner, M., and J.-Å. Gustafsson. Induction of cytochrome P450 in the rat brain by ethanol. Proc. Natl. Acad. Sci. USA 91:1019-1023 (1994).
16. Lazar, R. B., S. U. Ho, O. Melen, and A. N. Daghestani. Multifocal central nervous system damage caused by toluene abuse. Neurology 33:1337-1340 (1983).
17. Nakajima, T., and R. S. Wang. Induction of cytochrome P450 by toluene. Int. J. Biochem. 26:1333-1340 (1994).
18. Meltzerr, H. Y. An overview of the mechanism of action of clozapine. J. Clin. Psychiatr. 55: (Suppl B): 47-52 (1994).
19. Gardner, E. L., J. Chen, and W. Paredes. Clozapine produces potent antidopaminergic effects anatomically specific to the mesolimbic system. J. Clin. Psychiatr. 55: (Suppl B): 15-22 (1994).
20. 3-like receptors in the action of clozapine. J. Clin. Psychiatr. 55: (Suppl B): 23-26 (1994).
21. Seeman, P. Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-276 (1992).
22. Chromczynski, P., and N. Sacchi. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
24. Davis, L. G., M. D. Dibner, and J. F. Battey. Basic Methods in Molecular Biology. Elsevier, The Netherlands (1986).
25. Omura, T., and R. Sato. The carbon monoxide-binding pigment of liver microsomes: evidence for its hemoprotein nature. J. Biol. Chem. 239:2370-2378 (1964).
26. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
27. Strömstedt, M., M. Warner, and J.-Å. Gustafsson. Cytochrome P450s of the 4A subfamily in the brain. J. Neurochem. 63:671-676 (1994).
28. Zaphiropoulos, P. G., and T. Wood. Identification of the major cytochrome P450s of subfamily 2C that are expressed in brain of female rats and in olfactory lobes of ethanol treated male rats. Biochem. Biophys. Res. Commun. 193:1006-1013 (1993).
29. Harada, N., and K. Yamada. Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. Endocrinology 131:2306-2312 (1992).
30. Sachs, A., and E. Wahle. Poly(A) tail metabolism and function in eucaryotes. J. Biol. Chem. 268:22955-22958 (1993).
31. Huarte, J., A. Stutz, M. L. O'Connell, P. Gubler, D. Belin, A. L. Darrow, S. Strickland, and J. D. Vassalli. Transient translational silencing by reversible mRNA deadenylation. Cell 69:1021-1030 (1992).
32. 3H]spiperone binding sites linked to dopamine receptors. Toxicol. Lett. 17:275-281 (1983).
33. Mattia, C. J., S. F. Ali, and S. C. Bondy. Toluene-induced oxidative stress in several brain regions and other organs. J. Mol. Chem. Neuropathol. 18:313-328 (1993).
34. Nakajima, T., R. S. Wang, E. Elovaara, S. S. Park, H. V. Gelboin, E. Hietanen, and H. Vainio. Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver. Biochem. Pharmacol 41:395-404 (1991).
35. Suzuki, T., S. Fujita, S. Narimatsu, Y. Masubuchi, M. Tachibana, S. Ohta, and M. T. Hirobe. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. FASEB J. 6:771-776 (1992).